An agent cleaving glucose-derived protein crosslinks in vitro and in vivo

[1]  M. Cybulsky,et al.  Advanced Glycation Endproducts Promote Adhesion Molecule (VCAM-1, ICAM-1) Expression and Atheroma Formation in Normal Rabbits , 1995, Molecular medicine.

[2]  S. Grundy,et al.  Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[3]  M. Smith,et al.  Advanced Maillard reaction end products are associated with Alzheimer disease pathology , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[4]  R. Bucala,et al.  Advanced glycation end products contribute to amyloidosis in Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[5]  N. Taniguchi,et al.  beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. , 1993, The Journal of clinical investigation.

[6]  A. Cerami,et al.  Mechanism of Inhibition of Advanced Glycosylation by Aminoguanidine in Vitro , 1993 .

[7]  R. Bucala,et al.  Lipid advanced glycosylation: pathway for lipid oxidation in vivo. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[8]  S. Krungkrai,et al.  Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[9]  E. Friedman,et al.  Hemoglobin-AGE: a circulating marker of advanced glycosylation. , 1992, Science.

[10]  G. Striker,et al.  Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[11]  R. Bucala,et al.  Immunochemical detection of advanced glycosylation end products in vivo. , 1992, The Journal of biological chemistry.

[12]  E. Schleicher,et al.  New Aspects of the Maillard Reaction in Foods and in the Human Body , 1990 .

[13]  F. Ledl,et al.  Formation of an Aminoreductone from Glucose , 1990 .

[14]  P. Anthony.  Robbins' Pathologic Basis of Disease , 1990 .

[15]  H. Gerlach,et al.  Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties , 1989, The Journal of experimental medicine.

[16]  K. Manogue,et al.  Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. , 1988, Science.

[17]  J. Rousseaux,et al.  Evidence for an increased glycation of IgG in diabetic patients. , 1987, Clinica chimica acta; international journal of clinical chemistry.

[18]  C. Elmets,et al.  Relation between complications of type I diabetes mellitus and collagen-linked fluorescence. , 1986, The New England journal of medicine.

[19]  J. Baynes,et al.  Nonenzymatic glucosylation and glucose-dependent cross-linking of protein. , 1983, The Journal of biological chemistry.

[20]  J. Bochantin,et al.  Age-dependence of collagen tail fiber breaking strength in Sprague-Dawley and fischer 344 rats , 1981, Experimental Gerontology.

[21]  H. Stegemann,et al.  Determination of hydroxyproline. , 1967, Clinica chimica acta; international journal of clinical chemistry.

[22]  貞二 鵜飼,et al.  アチロイン縮合に於ける新觸媒群に就て (第1報) チアツオリウム鹽基或は共核開裂成績體の作用 , 1943 .

[23]  R. Bucala,et al.  Advanced glycosylation: chemistry, biology, and implications for diabetes and aging. , 1992, Advances in pharmacology.

[24]  M. Itakura,et al.  Aminoguanidine decreases urinary albumin and high-molecular-weight proteins in diabetic rats. , 1991, Life Science.

[25]  V. Monnier,et al.  Accelerated age-related browning of human collagen in diabetes mellitus. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[26]  S. Robbins,et al.  Pathologic basis of disease , 1974 .